We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back to Event-Details

International Pharmacovigilance

DIAmond Sessions

Day & Time:
April 17, 11:00AM - 12:30PM (Central Europe Standard Time)

Session Number:

Room Number:


International Pharmacovigilance

Esteban Herrero-Martinez, PhD
Director Regulatory Policy and Intelligence
Abbvie Ltd, United Kingdom

Pharmacovigilance is of increasing focus and importance internationally. Although welcome, huge variations in approach, legislative maturity, resource and fast-moving change are a challenge for all. We all have a responsibility to support development of effective pharmacovigilance systems globally to protect patients and support medicine delivery. With multiple activities worldwide and scarce resources, important key stakeholders must understand each other’s activities and support each other to achieve the same ultimate objectives.

Presentation(s) & Speaker(s):
Panel Discussion
Amr Saad
Former Associate Minister of Health for Pharmaceutical Affairs
Founder, The Egyptian Pharmacovigilance Center (EPVC) , Egypt

Panel Discussion
Bahija Gouimi
AMAL, Morocco

Panel Discussion
Raj Long, MEd, MSc
Senior Regulatory Officer, Integrated Development, Global Health
Bill and Melinda Gates Foundation, United Kingdom

Panel Discussion
Emer Cooke, MBA
Head of Regulation of Medicines and other Health Technologies
World Health Organization (WHO) , Switzerland

Panel Discussion
June Munro Raine, MD, MSc
Director - VRMM & Chairman of the PRAC
MHRA, United Kingdom

Panel Discussion
Sue Rees, MS
EU QPPV, Executive Director, Global Patient Safety
Amgen Ltd, United Kingdom

Panel Discussion
Xavier Kurz, MD
Head of Surveillance and Epidemiology Service
European Medicines Agency, European Union, United Kingdom